Reduction of Excessive Visceral Fat and Safety with 52-Week Administration of Lipase Inhibitor Orlistat in Japanese: Long-Term Clinical Study

INTRODUCTION: Orlistat is an inhibitor of pancreatic lipase and is used as an anti-obesity drug in many countries. However, there are no data available regarding the effects of orlistat on visceral fat (VF) accumulation in Japanese individuals. Therefore, this study aimed to analyze the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirai, Kohji, Tanaka, Michitaka, Fujita, Toru, Fujii, Yuka, Shimomasuda, Masatsugu, Sakai, Soichi, Samukawa, Yoshishige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318244/
https://www.ncbi.nlm.nih.gov/pubmed/30387022
http://dx.doi.org/10.1007/s12325-018-0822-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318244/
https://www.ncbi.nlm.nih.gov/pubmed/30387022
http://dx.doi.org/10.1007/s12325-018-0822-x

Ejemplares similares